Similar articles

• To which extent is the clinical use of dextran, gelatin and hydroxyethyl starch influenced by the incidence and severity of anaphylactoid reactions?

  Collins JA, Litwin MS, Lutz H, Klose R, Ring J, Thorén L, Tschirren B, Lundsgaard-Hansen P. Collins JA, et al. Vox Sang. 1979;36(1):39-49. doi: 10.1111/j.1423-0410.1979.tb04398.x. Vox Sang. 1979. PMID: 85370 No abstract available.
• [Intravascular persistence, tissue storage and excretion of hydroxyethyl starch (HAS)].

  Thompson WL, Fukushima T, Rutherford RB, Walton RP. Thompson WL, et al. Infusionsther Klin Ernahr. 1979 Jun;6(3):151-5. Infusionsther Klin Ernahr. 1979. PMID: 88413 German.
• [Blood volume replacement using hydroxyethyl starch or Dextran 60].

  Hölscher B. Hölscher B. Infusionstherapie (1973). 1974 Apr;1(4):281-5. Infusionstherapie (1973). 1974. PMID: 4142945 German. No abstract available.
• Rational use of albumin and plasma substitutes.

  Thompson WL. Thompson WL. Johns Hopkins Med J. 1975 May;136(5):220-5. Johns Hopkins Med J. 1975. PMID: 47936 Review.
• [Effects and adverse effects of colloid-containing solutions].

  Bergmann H. Bergmann H. Beitr Infusionther Klin Ernahr. 1979;2:43-50. Beitr Infusionther Klin Ernahr. 1979. PMID: 94260 Review. German. No abstract available.